Top Markets
Coin of the day
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.

ADGI
Classement en actions #16450
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily... Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.
Prix de l'action
$4.64
Dernière synchronisation: 2022-09-12
Capitalisation boursière
$293.43M
Changement (1 jour)
0.87%
Changement (1 an)
0.00%
Pays
US
Échange Adagio Therapeutics, Inc. (ADGI)

Catégorie

Le prix ADGI avec la capitalisation boursière de B
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.
ADGI
$4.64
Capitalisation boursière de Adagio Therapeutics, Inc.(ADGI)
Capitalisation boursière: $293.43M
En September 2026, Adagio Therapeutics, Inc. a une capitalisation boursière de $293.43M. Cela fait de Adagio Therapeutics, Inc. la 16450th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Adagio Therapeutics, Inc. du 2021 au 2026
ADGI par rapport au top 5 des plus populaires stocks
Prix pour ADGI L’actif B La capitalisation boursière de B Résultats
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.
$83,169.03 $293.43M
$5.260T +1,792,336.04%
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.
$75,561.85 $293.43M
$4.779T +1,628,388.14%
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.
$63,515.83 $293.43M
$4.017T +1,368,775.61%
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.
$58,812.61 $293.43M
$3.719T +1,267,413.16%
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.
$43,235.92 $293.43M
$2.734T +931,708.65%